Saliva is vital for oral health. It is essential for the hydration of the oral mucosa;it provides lubrication, begins nutrient digestion and imparts antimicrobial and mechanical protection for the mouth and upper gastrointestinal tract. Reduced flow of saliva results in """"""""dry mouth"""""""" (xerostomia) and greatly impacts the quality of life of sufferers. A major cause of salivary gland hypofunction is Sjogrens syndrome (SS), a relatively common autoimmune exocrinopathy affecting the salivary and lacrimal glands. SS results in progressively worsening dry mouth and dry eye (xerophthalmia) as significant glandular tissue is ultimately destroyed following lymphocyte infiltration. Significantly, in established animal models of SS, such as the IL14a B cell """"""""knock-in"""""""" mouse, or the C57BL/6.NOD-Aec1Aec2 mouse, signaling events and fluid flow are markedly decreased prior to any evidence of destruction of glandular tissue. Moreover, morphologically intact tissue is often retained in SS patients, but paradoxically, is apparently refractory to stimulation. Given this information, this project will tst the hypothesis that defects in stimulus-secretion coupling are responsible for decreased saliva formation early in the disease and in remaining functional tissue as the disease progresses. The proposal will utilize mouse models of SS to probe the underlying defects in pathways leading to fluid and protein secretion from salivary and lacrimal glands as the disease develops. Important findings in mouse models will be validated by performing similar experiments in labial gland biopsies from SS patients.
In specific aim 1, experiments will be performed to ascertain why intracellular Ca2+ signaling, the primary stimulus for fluid secretion is compromised in SS mouse models. Experiments will determine whether the production of second-messengers is compromised in SS. Multi-photon imaging in gland lobules together with high-speed wide-field imaging, combined with focal flash photolysis in isolated acini, will question if the machinery responsible for Ca2+ release, Ca2+ influx or Ca2+ clearance is altered in SS.
In specific aim 2, experiments will be performed to elucidate why the exocytosis of protein is attenuated in SS models and if the function of ion channels necessary for fluid secretion is altered. Multi-photon imaging of fluid phase markers together with capacitance measurements of cell membrane surface area will be used to monitor exocytosis. We will determine whether signaling, or the exocytotic machinery in SS is disrupted. Finally, we will evaluate if the function of Ca2+- activated Cl- and K+ channels are altered in SS. These studies are designed to provide fundamental information regarding the functional changes occurring in stimulus-secretion coupling in SS. The ultimate goal of this project is to use this knowledge to rationale design and test strategies for the rescue and maintenance of secretion based on exploiting the physiology of remaining functional secretory tissue in SS.

Public Health Relevance

Saliva and tears are fluids which are essential for maintaining a healthy mouth and eyes. Sjogrens syndrome is a common disease where the secretion of these fluids is decreased resulting in major health problems for the afflicted. This study is designed to define the reasons why outwardly healthy tissue which remains in these patients does not adequately secrete these fluids. Ultimately this information may be used to design therapies for this serious health issue.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
5R01DE014756-11
Application #
8468675
Study Section
Special Emphasis Panel (ZRG1-MOSS-C (90))
Program Officer
Burgoon, Penny W
Project Start
2002-08-15
Project End
2017-05-31
Budget Start
2013-06-01
Budget End
2014-05-31
Support Year
11
Fiscal Year
2013
Total Cost
$464,634
Indirect Cost
$163,900
Name
University of Rochester
Department
Pharmacology
Type
Schools of Dentistry
DUNS #
041294109
City
Rochester
State
NY
Country
United States
Zip Code
14627
Almássy, János; Siguenza, Elias; Skaliczki, Marianna et al. (2018) New saliva secretion model based on the expression of Na+-K+ pump and K+ channels in the apical membrane of parotid acinar cells. Pflugers Arch 470:613-621
Wang, Liwei; Yule, David I (2018) Differential regulation of ion channels function by proteolysis. Biochim Biophys Acta Mol Cell Res :
Nurbaeva, Meerim K; Eckstein, Miriam; Devotta, Arun et al. (2018) Evidence That Calcium Entry Into Calcium-Transporting Dental Enamel Cells Is Regulated by Cholecystokinin, Acetylcholine and ATP. Front Physiol 9:801
Terry, Lara E; Alzayady, Kamil J; Furati, Esraa et al. (2018) Inositol 1,4,5-trisphosphate Receptor Mutations associated with Human Disease. Messenger (Los Angel) 6:29-44
Wang, Liwei; Wagner 2nd, Larry E; Alzayady, Kamil J et al. (2018) Region-specific proteolysis differentially modulates type 2 and type 3 inositol 1,4,5-trisphosphate receptor activity in models of acute pancreatitis. J Biol Chem 293:13112-13124
Wang, Liwei; Wagner 2nd, Larry E; Alzayady, Kamil J et al. (2017) Region-specific proteolysis differentially regulates type 1 inositol 1,4,5-trisphosphate receptor activity. J Biol Chem 292:11714-11726
Ivanova, Hristina; Ritaine, Abigael; Wagner, Larry et al. (2016) The trans-membrane domain of Bcl-2?, but not its hydrophobic cleft, is a critical determinant for efficient IP3 receptor inhibition. Oncotarget 7:55704-55720
Concepcion, Axel R; Vaeth, Martin; Wagner 2nd, Larry E et al. (2016) Store-operated Ca2+ entry regulates Ca2+-activated chloride channels and eccrine sweat gland function. J Clin Invest 126:4303-4318
Gerber, Sylvie; Alzayady, Kamil J; Burglen, Lydie et al. (2016) Recessive and Dominant De Novo ITPR1 Mutations Cause Gillespie Syndrome. Am J Hum Genet 98:971-980
Chandrasekhar, Rahul; Alzayady, Kamil J; Wagner 2nd, Larry E et al. (2016) Unique Regulatory Properties of Heterotetrameric Inositol 1,4,5-Trisphosphate Receptors Revealed by Studying Concatenated Receptor Constructs. J Biol Chem 291:4846-60

Showing the most recent 10 out of 57 publications